Valuation : Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 6.46B 963M 829M 780M 712M 1.33B 90.92B 1.34B 9.21B 3.57B 46.65B 3.62B 3.54B 150B P/E 2026 *
13.9x
P/E 2027 * 11.7x
Enterprise Value 5.23B 778M 670M 630M 576M 1.08B 73.49B 1.08B 7.45B 2.89B 37.71B 2.92B 2.86B 121B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.27x
Free-Float
51.88%
Yield 2026 *
3.32%
Yield 2027 * 4.52%
1 day-0.18%
1 week+0.09%
Current month+0.99%
1 month-2.34%
3 months+0.72%
6 months-12.10%
Current year-12.44%
1 week 11.06
Extreme 11.06
11.38
1 month 11.06
Extreme 11.06
12.91
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.33
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/26 Buy

Founder

1,359,000 0.3397%
12/5/26 Sell

Founder

-2,727,600 0.6818%
11/5/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+0.09%-24.83%-49.91% 963M
+2.94%+1.04%-42.45%-16.15% 15.07B
+0.44%-1.03%-17.86%-10.09% 6.55B
+3.29%-0.16%-51.62%-34.31% 6.47B
+0.04%+0.09%-8.40%-19.39% 4.14B
+1.51%+3.53%+9.88%-27.56% 3.19B
-0.97%-2.34%-20.47%-38.54% 3.17B
-1.50%-0.23%-44.24%-26.16% 2.94B
+1.59%+10.01%+43.20% - 2.58B
+2.42%-5.49%-18.52%-10.30% 2.5B
Average +0.96%+0.73%-17.53%-25.82% 4.76B
Weighted average by Cap. +1.60%+0.55%-26.23%-21.62%

Financials

2026 *2027 *
Net sales 17.73B 2.64B 2.27B 2.14B 1.95B 3.65B 249B 3.66B 25.27B 9.8B 128B 9.92B 9.7B 412B 18.76B 2.79B 2.4B 2.26B 2.07B 3.87B 264B 3.88B 26.73B 10.37B 135B 10.49B 10.26B 436B
Net income 470M 69.95M 60.19M 56.63M 51.73M 96.77M 6.6B 97.04M 669M 260M 3.39B 263M 257M 10.92B 560M 83.46M 71.82M 67.57M 61.73M 115M 7.88B 116M 799M 310M 4.04B 313M 307M 13.03B
Net Debt -1.24B -185M -159M -149M -136M -255M -17.42B -256M -1.77B -685M -8.94B -693M -678M -28.79B -1.42B -212M -182M -172M -157M -293M -20.02B -294M -2.03B -787M -10.27B -796M -779M -33.09B
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
04/09/26 CNY 11.26 -0.18% 5,340,583
03/09/26 CNY 11.28 +0.27% 5,090,893
02/09/26 CNY 11.25 -0.71% 5,876,099
01/09/26 CNY 11.33 +1.61% 7,535,037
31/08/26 CNY 11.15 -0.89% 6,390,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.26CNY
Average target price
13.39CNY
Spread / Average Target
+18.92%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock